However, autocrine CXCL12 is not the main initiator of CAF contractility, highlighting its distinct functions in promoting a permeable endothelium that is more prone to angiogenesis and tumor cell intravasation (Holter et al., 2022). This evidence concerns the gene CXCL12 and neoplasm.